Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 6/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.36 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.36 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.35 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL900808 | 0.82 | ESR1 (0.57) | ESR1ESR2ALDH1A1L3MBTL1ADORA3 | |
| SCHEMBL9472582 | 0.82 | ESR1 (0.57) | ESR1ESR2ALDH1A1L3MBTL1ADORA3 | |
| SCHEMBL29119959 | 0.81 | ALDH1A1 (0.40) | ESR1ESR2ALDH1A1ADORA3LMNA | |
| SCHEMBL9472246 | 0.80 | ESR1 (0.55) | ESR1ESR2ALDH1A1L3MBTL1ADORA3 | |
| Cyclohexane SCHEMBL28345268 | 0.80 | ALDH1A1 (0.52) | ESR1ESR2ALDH1A1LMNAMAPT | |
| SCHEMBL9471910 | 0.79 | RXRA (0.56) | ESR1ESR2ALDH1A1L3MBTL1ADORA3 | |
| SCHEMBL29119934 | 0.78 | ALDH1A1 (0.41) | ALDH1A1MAPTRXRAHDAC4AKR1C1 | |
| SCHEMBL31712141 | 0.78 | ESR1 (0.77) | ESR1ESR2ALDH1A1L3MBTL1ADORA3 | |
| SCHEMBL517000 | 0.78 | ESR1 (0.77) | ESR1ESR2ALDH1A1L3MBTL1ADORA3 | |
| SCHEMBL11990115 | 0.78 | ALOX15 (0.59) | ESR1ESR2ALDH1A1L3MBTL1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3187514-B1 | POLYMERIZABLE MONOMER, CURABLE COMPOSITION AND RESIN MEMBER | TOKUYAMA DENTAL CORP (JP) | 2020-07-29 | — | — | EP | disclosed |
| US-20190300472-A1 | POLYMERIZABLE MONOMER, METHOD OF PRODUCING POLYMERIZABLE MONOMER, CURABLE COMPOSITION AND RESIN MEMBER | TOKUYAMA DENTAL CORPORATION (JP) | 2019-10-03 | — | — | US | disclosed |
| EP-3187514-A1 | POLYMERIZABLE MONOMER, CURABLE COMPOSITION AND RESIN MEMBER | Tokuyama Dental Corporation (JP) | 2017-07-05 | — | — | EP | disclosed |
| US-9529285-B2 | Polycarbonate copolymer, and coating liquid and electrophotographic photosensitive body using same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-12-27 | — | — | US | disclosed |
| US-9529285-B2 | Polycarbonate copolymer, and coating liquid and electrophotographic photosensitive body using same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-12-27 | — | — | US | disclosed |
| US-20140363760-A1 | POLYCARBONATE COPOLYMER, AND COATING LIQUID AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE BODY USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2014-12-11 | — | — | US | disclosed |
| US-20140363760-A1 | POLYCARBONATE COPOLYMER, AND COATING LIQUID AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE BODY USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2014-12-11 | — | — | US | disclosed |
| US-5183926-A | Process for the preparation of aromatic dicarboxylic acids and aromatic hydrocarbons | BAYER AKTIENGESELLSCHAFT (DE) | 1993-02-02 | — | — | US | disclosed |
| EP-0414062-A2 | Process for preparing aromatic dicarboxylic acids and novel aromatic dicarboxylic acids | BAYER AG (DE) | 1991-02-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190300472-A1 | POLYMERIZABLE MONOMER, METHOD OF PRODUCING POLYMERIZABLE MONOMER, CURABLE COMPOSITION AND RESIN MEMBER | CHRM1, CHRM2, H1-0 | ESR1 797/4885ESR2 1354/4885ALDH1A1 1842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.